Deficiency of Mouse FHR-1 Homolog, FHR-E, Accelerates Sepsis, and Acute Kidney Injury Through Enhancing the LPS-Induced Alternative Complement Pathway

Xiangru Li,Zhenhua Hao,Xiaorong Liu,Wei Li
DOI: https://doi.org/10.3389/fimmu.2020.01123
IF: 7.3
2020-06-19
Frontiers in Immunology
Abstract:Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of factor H-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types of nephropathy when an inducer such as infection exists. However, the underlying mechanism of the disease development is largely unknown. There is no report on <i>CFHR1</i> gene knockout in any animal infection model and its function <i>in vivo</i> is still unclear. Here, a <i>Cfhr1</i> knockout mouse was generated for investigating AP in sepsis and sepsis-induced acute kidney injury (AKI). We found that murine FHR-1 homolog (FHR-E) deficiency enhanced lipopolysaccharide (LPS)-induced AP activation both <i>in vitro</i> and <i>in vivo</i> and that <i>Cfhr1</i> knockout mice exhibited more severe sepsis and AKI in response to LPS challenge. These results indicated that FHR-E deficiency promoted LPS-induced sepsis and AKI through AP over-activation, providing a mouse model for studying AP regulation and sepsis. This study revealed the function of FHR-E <i>in vivo</i>, which may further provide hints to the pathogenesis of FHR-1 deficiency-related diseases by enhancing LPS-induced AP activation.
immunology
What problem does this paper attempt to address?